title: Synthesis and alpha 2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogues in human platelets.
abstract: It is known that the steric requirements for the interactions of catecholamines and catecholimidazolines with alpha 1- and alpha 2-adrenoceptors are different. New analogues of desoxycatecholimidazoline (1), desoxycatecholimidazole (3), benzylic hydroxyl substituted imidazole (4), and the aromatic fluorine substitution analogues of 1 at the 2 (5), 5 (6), and 6 (7) positions, and a set of asymmetric 4-substituted catecholimidazolines, S-8 and R-8, were prepared and tested for interaction with alpha 2-adrenoceptors in human platelets. With the exception of 3, all compounds were selective for alpha-adrenoceptor-mediated responses in human platelets. Introduction of a double bond in imidazoline 1 to give an imidazole 3 or the introduction of a benzylic hydroxyl group to 3, as in 4, reduced the inhibition of platelet aggregation with a rank order potency of 1 greater than 3 greater than 4. Fluorine atom substitution at the 2-, 5-, or 6-positions only slightly modified the inhibitory activity of 1. Each analogue (1, 3-7) produced alpha 2-mediated inhibition of platelet adenylate cyclase and can be classified as a partial agonist. The inhibition potency of S-8 and R-8 against epinephrine-induced aggregatory responses were greatly different, and only R-8 and 4 were alpha 2-agonists on human platelet function. Our studies provide further evidence for the differential interaction of catecholamines and catecholimidazolines in alpha 1- and alpha 2-adrenoceptor systems.
authors.affiliation: Division of Medicinal Chemistry, College of Pharmacy, Ohio State University, Columbus 43210.
authors.forename: D D
authors.initials: DD
authors.lastname: Miller
authors.forename: A
authors.initials: A
authors.lastname: Hamada
authors.forename: M T
authors.initials: MT
authors.lastname: Clark
authors.forename: A
authors.initials: A
authors.lastname: Adejare
authors.forename: P N
authors.initials: PN
authors.lastname: Patil
authors.forename: G
authors.initials: G
authors.lastname: Shams
authors.forename: K J
authors.initials: KJ
authors.lastname: Romstedt
authors.forename: S U
authors.initials: SU
authors.lastname: Kim
authors.forename: U
authors.initials: U
authors.lastname: Intrasuksri
authors.forename: J L
authors.initials: JL
authors.lastname: McKenzie
mesh_terms: D001792:Blood Platelets / Q000187:drug effects*; D002395:Catecholamines / Q000138:chemical synthesis* / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D013329:Structure-Activity Relationship
chemical_list: D002395:Catecholamines; D007093:Imidazoles; D011942:Receptors, Adrenergic, alpha; D004837:Epinephrine